Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Pummer

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Cancer Medicine|January 20, 2018
Risk stratification for febrile neutropenia in patients with testicular germ cell tumorsAngelika Terbuch, Florian Posch, Richard Partl, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
European Urology|October 29, 2010
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer stagingMarco Auprich, Felix K-H Chun, John F Ward, et al.
BJU International|November 15, 2011
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomyThomas F Chromecki, Eugene K Cha, Karl Pummer, et al.
Cancers|May 14, 2020
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell CancerMaximilian Seles, Georg C Hutterer, Johannes Foßelteder, et al.
Anticancer Research|October 2, 2019
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell TumorsAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Nature Communications|June 23, 2016
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerPeter Ulz, Jelena Belic, Ricarda Graf, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
Urologic Oncology|December 3, 2014
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic modelIlaria Lucca, Shahrokh F Shariat, Alberto Briganti, et al.
International Journal of Molecular Sciences|October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor PatientsAngelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Cancer Medicine|January 20, 2018
Risk stratification for febrile neutropenia in patients with testicular germ cell tumorsAngelika Terbuch, Florian Posch, Richard Partl, et al.
European Urology|July 13, 2010
External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcomeMarco Auprich, Alexander Haese, Jochen Walz, et al.
European Urology|October 29, 2010
Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer stagingMarco Auprich, Felix K-H Chun, John F Ward, et al.
BJU International|November 15, 2011
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomyThomas F Chromecki, Eugene K Cha, Karl Pummer, et al.
Cancers|May 14, 2020
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell CancerMaximilian Seles, Georg C Hutterer, Johannes Foßelteder, et al.
Anticancer Research|October 2, 2019
Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell TumorsAngelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Nature Communications|June 23, 2016
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerPeter Ulz, Jelena Belic, Ricarda Graf, et al.
Plos One|April 22, 2017
Risk stratification for venous thromboembolism in patients with testicular germ cell tumorsAngelika Bezan, Florian Posch, Ferdinand Ploner, et al.
Urologic Oncology|December 3, 2014
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic modelIlaria Lucca, Shahrokh F Shariat, Alberto Briganti, et al.
International Journal of Molecular Sciences|October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor PatientsAngelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Pageof 11